2A85.6ICD-11 MMS 2026-01
Burkitt lymphoma including Burkitt leukaemia
Description
A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures. It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients. Three morphologic variants are recognised: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma. All cases express the MYC translocation [t(8;14)].
Index terms
- Burkitt lymphoma including Burkitt leukaemia
- Burkitt tumour
- diffuse small noncleaved malignant Burkitt lymphoma
Show allHide
- malignant Burkitt lymphoma
- small noncleaved cell Burkitt lymphoma
- undifferentiated Burkitt lymphoma
- “Burkitt-like” lymphoma
- Mature B-cell leukaemia Burkitt-type
- Burkitt cell leukaemia
- Burkitt type acute lymphoblastic leukaemia
- mature B-cell leukaemia Burkitt-type without mention of remission
- Mature B-cell leukaemia Burkitt-type in complete remission
Inclusions
- “Burkitt-like” lymphoma
Exclusions from above levels
2E03– Malignant neoplasm metastasis in bone or bone marrow- http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
- http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland
Sibling codes
2A85.0– Nodal marginal zone lymphoma2A85.1– Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach2A85.2– Extranodal marginal zone B-cell lymphoma, primary site skin2A85.3– Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin2A85.4– Lymphoplasmacytic lymphoma2A85.5– Mantle cell lymphoma2A85.Y– Further specified mature B-cell neoplasms or lymphoma
Foundation entity
Burkitt lymphoma including Burkitt leukaemia – http://id.who.int/icd/entity/2100138081
Allowed postcoordination axes
Part of: 2A85: Other specified mature B-cell neoplasms or lymphoma › 02: Neoplasms